Study Overview
Details
NCTId: NCT02467686
Status: Unknown status
Condition: Sexuality
Study Type: Interventional
Sponsor: Irmandade da Santa Casa de Misericordia de Sao Paulo
Study Description
Brief
The purpose of this study is to evaluate the Cimicifuga racemosa effects on the sexuality of women with Breast cancer using tamoxifen or aromatase inhibitor through questionnaires.
Detailed
For the study will be recruited 60 women treated with breast cancer, using tamoxifen or aromatase inhibitor, are in menopause, hot flashes and has with or without sexual life. They will answer the questionnaires: Kupperman, World Health Organization Quality of Life (WHOQOL) and those sexually active will have Female Sexual Function Index (FSFI). The control group will have 30 patients using tamoxifen alone or inhibitor. The other group will have 30 patients receiving tamoxifen or inhibitor and will start with 2 tablets per day of dry extract of Cimicifuga racemosa. They will be followed for 6 months and answer questionnaires at the first visit, 3-month and 6-month follow-up.
Eligibility
Criteria:
Inclusion Criteria:
Menopausal women with breast cancer treated and using tamoxifen or aromatase inhibitor.
With hot flashes and with or without active sexual life.
Exclusion Criteria:
Women did not have breast cancer
do not use tamoxifen or aromatase inhibitor
not in menopause and not have hot flashes
Healthy Volunteers: Accepts Healthy Volunteers
Gender: Female
Min Age: 48 Years
Max Age: 68 Years
Contacts
Carolina Furtado Macruz
Recruiting
Sao Paulo
01225001
Brazil
Carolina Macruz
Contact
+5511999141447
